more_reports

Sernova Biotherapeutics Inc.

SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA

streetwise book logo Streetwise Company Fact Sheet

2025/5/20 23:37:51

(SVA:TSX.V - SEOVF:OTCQB - PSH:XETRA)

Analyst coverage

Rodman & RenshawDr. Tony Butler
Raymond JamesMichael Freeman
Leede Financial Inc.Dr. Douglas Loe
Leede Jones GableDoug Loe
H.C. Wainwright & Co.Dr. Joseph Pantginis
Echelon Capital MarketsStefan Quenneville
Raymond JamesRahul Sarugaser
Research Capital CorporationDr. Andre Uddin

Newsletter coverage

Company News

View Latest News

Streetwise Reports Articles

05/15/2025 - View Article
04/28/2025 - View Article
04/03/2025 - View Article
04/03/2025 - View Article
03/10/2025 - View Article

streetwise book logoStreetwise - Sernova Biotherapeutics Inc. Ownership Overview*

Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA)

*Share Structure as of 5/15/2025

Company News 

5/14/2025 – Sernova Biotherapeutics Provides Positive Interim Data from Ongoing Phase 1/2 Clinical Trial of Cell Pouch Bio-hybrid Organ in Patients Living with Type 1 Diabetes

4/17/2025 – Sernova Biotherapeutics Secures $4 Million Loan to Further Advance its Clinical Development Plans

4/15/2025 – Sernova Biotherapeutics Cell Pouch Bio-hybrid Organ to be Highlighted at Cell & Gene Meeting on the Med

4/1/2025 – Sernova Biotherapeutics Provides Update on Phase 1/2 Clinical Trial of Cell Pouch(TM) Bio-Hybrid Organ for Treatment of Type 1 Diabetes

3/3/2025 – Sernova Biotherapeutics Receives FDA Clearance for IND Application for its Cell Pouch Bio-hybrid Organ with Autograft Thyroid Cells in Patients with Hypothyroidism